Precigen (PGEN)
(Real Time Quote from BATS)
$0.98 USD
+0.01 (0.92%)
Updated Sep 10, 2024 11:04 AM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Balance Sheet
Fiscal Year End for Precigen, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 63 | 99 | 115 | 100 | 75 |
Receivables | 2 | 14 | 21 | 17 | 26 |
Notes Receivable | 0 | 0 | 0 | 4 | 0 |
Inventories | 0 | 0 | 13 | 11 | 16 |
Other Current Assets | 4 | 5 | 7 | 17 | 117 |
Total Current Assets | 69 | 118 | 157 | 149 | 235 |
Net Property & Equipment | 7 | 7 | 34 | 35 | 61 |
Investments & Advances | 0 | 0 | 49 | 0 | 1 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 67 | 81 | 108 | 120 | 132 |
Deposits & Other Assets | 1 | 1 | 1 | 2 | 1 |
Total Assets | 151 | 216 | 360 | 315 | 456 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 2 |
Accounts Payable | 2 | 4 | 5 | 5 | 6 |
Current Portion Long-Term Debt | 0 | 43 | 0 | 0 | 32 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 14 | 30 | 23 | 18 | 26 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 6 | 0 | 4 | 17 | 53 |
Total Current Liabilities | 23 | 79 | 35 | 42 | 123 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 4 | 4 | 26 | 26 | 51 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 183 | 172 | 186 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 33 | 90 | 253 | 247 | 384 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 2,085 | 1,998 | 2,023 | 1,887 | 1,752 |
Retained Earnings | -1,964 | -1,869 | -1,916 | -1,823 | -1,653 |
Other Equity | -2 | -3 | 0 | 4 | -27 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 119 | 126 | 107 | 67 | 72 |
Total Liabilities & Shareholder's Equity | 151 | 216 | 360 | 315 | 456 |
Total Common Equity | 119 | 126 | 107 | 67 | 72 |
Shares Outstanding | 248.90 | 251.00 | 206.70 | 185.40 | 162.60 |
Book Value Per Share | 0.48 | 0.50 | 0.52 | 0.36 | 0.44 |
Fiscal Year End for Precigen, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 20 | 45 | 63 | 74 | 88 |
Receivables | 1 | 1 | 2 | 14 | 14 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 3 | 4 | 4 | 5 | 3 |
Total Current Assets | 24 | 50 | 69 | 93 | 106 |
Net Property & Equipment | 13 | 13 | 7 | 7 | 7 |
Investments & Advances | 0 | 0 | 0 | 5 | 7 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 30 | 65 | 67 | 77 | 80 |
Deposits & Other Assets | 0 | 1 | 1 | 1 | 1 |
Total Assets | 73 | 135 | 151 | 191 | 208 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 5 | 5 | 2 | 2 | 3 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 13 | 17 | 14 | 11 | 8 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 4 | 5 | 6 | 19 | 19 |
Total Current Liabilities | 23 | 29 | 23 | 33 | 31 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 2 | 4 | 4 | 4 | 4 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 30 | 38 | 33 | 43 | 41 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 2,093 | 2,088 | 2,085 | 2,083 | 2,080 |
Retained Earnings | -2,047 | -1,988 | -1,964 | -1,931 | -1,912 |
Other Equity | -3 | -3 | -2 | -4 | -3 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 43 | 97 | 119 | 148 | 166 |
Total Liabilities & Shareholder's Equity | 73 | 135 | 151 | 191 | 208 |
Total Common Equity | 43 | 97 | 119 | 148 | 166 |
Shares Outstanding | 252.70 | 248.90 | 248.90 | 255.40 | 255.40 |
Book Value Per Share | 0.17 | 0.39 | 0.48 | 0.58 | 0.65 |